Antiarrhythmic drug carvedilol inhibits HERG potassium channels [PDF]
Christoph A. Karle+6 more
openalex +1 more source
Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure [PDF]
Clyde W. Yancy+8 more
openalex +1 more source
Selective Laser Sintering 3D Printing of Carvedilol Tablets: Enhancing Dissolution Through Amorphization. [PDF]
Pešić N+5 more
europepmc +1 more source
Carvedilol Enhances Atrial and Brain Natriuretic Peptide mRNA Expression and Release in Rat Heart
Yoshimi Ohta+12 more
openalex +1 more source
Determination of Carvedilol in Human Cardiac Tissue by High-Performance Liquid Chromatography [PDF]
Frederike Behn+2 more
openalex +1 more source
Protective Effect of Carvedilol Against Oxidative Stress Induced by Palmitic Acid in Primary Rat Hepatocytes. [PDF]
Salas SAS+3 more
europepmc +1 more source
Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in β-adrenoceptor density and systolic function in rat cardiac myocytes [PDF]
Markus Flesch
openalex +1 more source
β-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress. [PDF]
Drygała S, Radzikowski M, Maciejczyk M.
europepmc +1 more source
Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore [PDF]
Paulo J. Oliveira+5 more
openalex +1 more source
Do Beta-Blockers Really Matter in Patients with Myocardial Infarction Without Left Ventricular Systolic Dysfunction? Comment on Sabina et al. Beta-Blockers in Patients with Myocardial Infarction and Preserved Left Ventricular Ejection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. <i>J. Clin. Med</i>. 2025, <i>14</i>, 150. [PDF]
Acerbo V, Cesaro A, Calabrò P.
europepmc +1 more source